Ignite Creation Date:
2024-05-06 @ 4:01 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04843215
Status:
RECRUITING
Last Update Posted:
2021-05-10
First Post:
2021-04-11
Brief Title:
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Study Overview
Official Title:
A Phase III Multicenter Prospective Randomized Controlled Clinical Trial Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer TOP-GC
Status:
RECRUITING
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase III multicenter prospective randomized controlled clinical trial to evaluate the impact of omentectomy for advanced gastric cancer on patient survival
Detailed Description:
In order to evaluate the impact of omentectomy for advanced gastric cancer on patient survival we designed this trial Patients who received curative gastrectomy were divided into two groups based on whether they underwent omentectomy The purpose of this study is to prove the non-inferiority of omentum preservation compared with omentectomy in patients with T3-T4a gastric cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None